Ivermectin is no longer profitable. Developed about 40 years...

  1. 576 Posts.
    Ivermectin is no longer profitable. Developed about 40 years ago, it went off patent many years ago. It's now produced by generic pharmaceutical manufacturers. The original manufacturer, Merck, is working on its own anti-Covid medication but not saying whether its based on Ivermectin. As it will be a 'new' formulation it will be patentable and thus a huge money-spinner for Merck if it proves to be effective.Could this be why they're so quiet about Ivermectin?

    The Japanese scientist who invented Ivermecitn won the Nobel Prize in 2015.
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.